Mode
Text Size
Log in / Sign up

ACIP Updates Recommendations for Pneumococcal Vaccine Use in U.S. AdultsHealth Panel Updates Pneumococcal Vaccine Recommendations for U.S. Adults

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consult the full ACIP statement for updated pneumococcal vaccine guidance in adults.

This publication consists of recommendations and reports from the Advisory Committee on Immunization Practices (ACIP) regarding pneumococcal vaccine use. The guidance is directed at U.S. adults aged 19 years and older. The document does not report on a specific study design, phase, sample size, or follow-up period, as it is a summary of committee deliberations and evidence review.

No intervention, comparator, or clinical outcomes from a new trial are detailed. The main results, primary and secondary outcomes, and specific numerical findings are not reported within this summary. The publication's purpose is to convey updated policy recommendations, not to present original research data.

Safety and tolerability data, including adverse events and discontinuation rates, are not reported. Key limitations of the evidence base informing the recommendations are not specified in the provided input. The direct practice relevance and any associated conflicts of interest are also not reported. This summary should be interpreted as a notification of updated guidance, and clinicians are advised to consult the complete ACIP statement for comprehensive clinical recommendations.

The Advisory Committee on Immunization Practices (ACIP), a group of medical experts that advises the U.S. Centers for Disease Control and Prevention (CDC), has released updated recommendations for pneumococcal vaccines. These vaccines help protect against serious illnesses like pneumonia, meningitis, and bloodstream infections caused by pneumococcal bacteria. The new guidance is for all adults in the United States aged 19 years and older.

The report outlines which specific pneumococcal vaccines are recommended for different age groups and for adults with certain health conditions or risk factors. It provides a schedule for when these vaccines should be given. The recommendations are based on the committee's review of existing evidence on vaccine safety, effectiveness, and public health needs.

This is an official update to public health policy, not a new scientific study testing the vaccines. The recommendations are meant to guide doctors and healthcare providers in offering the best possible protection to their patients. Adults should talk with their own doctor to understand how these updated recommendations apply to their personal health situation and vaccination history.

What this means for you:
A U.S. health panel has updated its official vaccine guidance. Talk to your doctor about what this means for you.

Study Details

EvidenceLevel 5
PublishedSep 2023
View Original Abstract ↓
This report describes ACIP recommendations for the use of pneumococcal vaccine in U.S. adults.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.